Beili Gao
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
A plain language summary of results from the CHOICE-01 trial of toripalimab plus chemotherapy for advanced non-small cell lung cancer (NSCLC).
Journal: Future oncology (London, England)
Published: December 04, 2024
Clinical and molecular characteristics, therapeutic strategies, and prognosis of non-small cell lung cancer patients harboring primary and acquired BRAF mutations.
Journal: Frontiers in oncology
Published: October 21, 2024
Camrelizumab plus carboplatin and pemetrexed as first-line therapy for advanced non-squamous non-small-cell lung cancer: 5-year outcomes of the CameL randomized phase 3 study.
Journal: Journal for immunotherapy of cancer
Published: October 10, 2024
Toripalimab plus chemotherapy for first line treatment of advanced non-small cell lung cancer (CHOICE-01): final OS and biomarker exploration of a randomized, double-blind, phase 3 trial.
Journal: Signal transduction and targeted therapy
Published: August 25, 2024
Circulating tumor DNA-based stratification strategy for chemotherapy plus PD-1 inhibitor in advanced non-small-cell lung cancer.
Journal: Cancer cell
Published: January 03, 2024
Emerging trends in the coexistence of primary lung Cancer and hematologic malignancy: a comprehensive analysis of clinicopathological features and genetic abnormalities.
Journal: Cancer cell international
Published: November 30, 2023
International expert consensus on diagnosis and treatment of lung cancer complicated by chronic obstructive pulmonary disease.
Journal: Translational lung cancer research
Published: May 26, 2023
SDH mutations, as potential predictor of chemotherapy prognosis in small cell lung cancer patients.
Journal: Discover oncology
Published: March 29, 2023
Camrelizumab Plus Carboplatin and Pemetrexed as First-Line Treatment for Advanced Nonsquamous NSCLC: Extended Follow-Up of CameL Phase 3 Trial.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: November 11, 2022
Toripalimab Plus Chemotherapy for Patients With Treatment-Naive Advanced Non-Small-Cell Lung Cancer: A Multicenter Randomized Phase III Trial (CHOICE-01).
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: October 07, 2022
Risk factors and prognostic role of renal adverse event in patients receiving immune checkpoint inhibitor therapy: analysis of data from a retrospective cohort study.
Journal: Annals of translational medicine
Published: July 01, 2022
Chinese expert consensus on the diagnosis and treatment of bone metastasis in lung cancer (2022 edition).
Journal: Journal of the National Cancer Center
Published: June 26, 2022
Last Updated: 09/26/2026